HLA ASSOCIATION OF ANTI-RO60 AND ANTI-RO52 ANTIBODIES IN SJOGRENS-SYNDROME

被引:20
|
作者
RICCHIUTI, V
ISENBERG, D
MULLER, S
机构
[1] INST BIOL MOLEC & CELLULAIRE, DEPT IMMUNOCHEM, CNRS, UPR 9021, F-67084 STRASBOURG, FRANCE
[2] UCL, DEPT MED, BLOOMSBURY RHEUMATOL UNIT, LONDON, ENGLAND
关键词
D O I
10.1006/jaut.1994.1045
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The possible pathological role of antibody subsets specific for different regions of 60-KD and 52-KD Ro/SSA proteins (Ro60 and Ro52) and La protein is unclear. Previously, we have shown that in patients with Sjogren's syndrome, the fine specificity of Ro60 and Ro52 antibodies, as characterized with synthetic peptides, varied considerably according to the origin of sera. We therefore looked for possible associations of HLA class I and class II alleles with Ro and La IgG antibodies in patients with primary Sjogren's syndrome (n=24) and secondary Sjogren's syndrome associated with systemic lupus erythematosus (n=25). Ro60 and Ro52 antibodies were tested by ELISA with the complete parent proteins and with 10 to 24 residue-long peptides of these proteins. Anti-Ro60 antibodies were more frequent in DR3-positive patients and in DQ1-negative patients whereas the presence of Ro52 and La IgG antibodies was significantly increased in patients with A1/B8/DR3 haplotype. Certain HLA associations observed with antibodies reacting with the whole Ro52 protein were not found with antibodies reacting with certain Ro60 and Ro52 peptides and, reciprocally, certain anti-peptide antibodies were linked to particular haplotypes whereas antibodies to the respective parent proteins were not linked to these haplotypes. Thus the production of antibody subsets reacting with different parts or presentations of Ro proteins is, at least in part, influenced immunologically by different HLA haplotypes, and this predisposition may play a role in the pathological development of the disease.
引用
收藏
页码:611 / 621
页数:11
相关论文
共 50 条
  • [21] Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases
    Robbins, Ailsa
    Hentzien, Maxime
    Toquet, Segolene
    Didier, Kevin
    Servettaz, Amelie
    Pham, Bach-Nga
    Giusti, Delphine
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [22] The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjogren's syndrome
    Deroo, L.
    Achten, H.
    De Boeck, K.
    Genbrugge, E.
    Bauters, W.
    Roels, D.
    Dochy, F.
    Creytens, D.
    Deprez, J.
    Van den Bosch, F.
    Elewaut, D.
    Peene, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (12) : 2310 - 2317
  • [23] ANTI-RO (SSA)/LA (SSB) ANTIBODIES AND SJOGRENS-SYNDROME
    MOUTSOPOULOS, HM
    ZERVA, LV
    CLINICAL RHEUMATOLOGY, 1990, 9 (01) : 123 - 130
  • [24] Prevalence and Clinical Significance of anti-Ro52 Antibodies in Antisynthetase Syndrome
    Narvaez, Javier
    Vidal-Montal, Paola
    Canadillas-Sanchez, Elena
    Maymo, Pol
    Palacios, Judith
    Aguilar, Marti
    Roig, Montserrat
    Nolla, Joan Miquel
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 595 - 597
  • [25] Anti-Ro52 antibodies in interstitial lung disease
    Chebbi, Donia
    Derbal, Samar
    Hentati, Olfa
    Cherif, Yousra
    Zamali, Imen
    Mrassi, Hana
    Blibech, Hana
    Ben Dahmen, Fatma
    Gharbi, Leila
    Louzir, Bechir
    Abdallah, Meya
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [26] ROLE OF THE ANTI-RO52 AND RO60 ANTIBODIES QUANTIFICATION IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Heredia, S.
    Martinez-Morillo, M.
    Riveros, A.
    Gifre, L.
    Teniente-Serra, A.
    Quirant, B.
    Holgado, S.
    Mateo, L.
    Prior, A.
    Garcia, Y.
    Camins, J.
    Martinez-Caceres, E.
    Olive, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1236 - 1236
  • [27] Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis
    Zachou, Kalliopi
    Gampeta, Stella
    Gatselis, Nikolaos K.
    Oikonomou, Katerina
    Goulis, John
    Manoussakis, Menelaos N.
    Renaudineau, Yves
    Bogdanos, Dimitrios P.
    Dalekos, George N.
    LIVER INTERNATIONAL, 2015, 35 (02) : 660 - 672
  • [28] ANTI-SLA/LP ALONE OR IN COMBINATION WITH ANTI-Ro52 AND FINE SPECIFICITY OF ANTI-Ro52 ANTIBODIES IN PATIENTS WITH AUTOIMMUNE HEPATITIS
    Zachou, K.
    Gabeta, S.
    Gatselis, N. K.
    Oikonomou, K.
    Goulis, I.
    Manoussakis, M. N.
    Renaudineau, Y.
    Bogdanos, D. P.
    Dalekos, G. N.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S199 - S199
  • [29] Assessing Commercial Titers of anti-Ro60 and Ro52 Antibodies to Risk Stratify Surveillance of Anti-Ro/SSA Antibody Positive Pregnancies
    Robins, Kimberly
    Bhan, Rohit
    Trad, Catherine
    Cohen, Rebecca
    Chang, Miao
    Wainwright, Benjamin
    Masson, Mala
    Mehta-Lee, Shilpi
    Izmirly, Peter
    Clancy, Robert
    Cuneo, Bettina
    Buyon, Jill
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [30] ANTI-Ro52 antibodies in suspected primary Sjogren's syndrome (PSS)
    Solans-Laque, Roser
    Loureiro, Jose
    Martinez, Ferran
    Puig, Javier
    Marin, Ana
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (03) : S280 - S280